In
the style of previous conferences this one covered topical and controversial
issues concerning the
actions and adverse effects of drugs used to control
chronic inflammatory conditions and pain. Among
the issues that have
been of recent concerns are:
The cardiovascular, hepato-renal and
gastro-intestinal reactions of the coxibs and the "knock-on"
effects to
safety considerations of the traditional NSAIDs.
Whether
traditional NSAIDs are in fact as good as coxibs and what place the coxibs have
in the short-
and long-term therapy of rheumatic diseases
The use of NSAIDs in prevention of chronic inflammatory
diseases, various cancers, Alzheimer's disease
and other neurodegenerative
conditions and the inflammatory mechanisms of these conditions and
important
therapeutic issues such as when to use NSAIDs and which drugs should be employed
in prevention
of these conditions.
On this occasion the
conference was a Festschrift in honour of Kim Rainsford who, with colleagues
and
collaborators, has been organiser of the Inflammopharmacology Conference
series since its inception in
1982. The first day of the conference as
the Festschrift featured contributions from Kim's colleagues, past and
present.
Committee
Chair and Coordinator Inflammopharmacology Conference 2008
Dr. Brian A
Callingham, Queens' College, Cambridge, U.K.
Email:
brian@inflammopharmacology.orgTel: +44(0)870 879
8334
Fax: +44(0)871 315 7046
Committee:
Prof. Richard Hunt, McMaster University,
Hamilton, ON, Canada
Prof. Walter Kean, McMaster University, Hamilton, ON,
Canada
Dr. Michael Powanda, Mill Valley, CA, USA
Prof. Ian Roger,
St Joseph's Healthcare & McMaster University, Hamilton, ON, Canada
Dr. Michael Seed, Queen
Mary University of London, UK
